| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |